| abstract |
The present invention provides a tablet having a high stability of an active ingredient (a potassium ion competitive acid blocker and acetaminosalicylic acid), and a pharmacological effect of the active ingredient after administration can be stabilized and rapidly expressed. The present invention is a tablet having an inner core and an outer layer. The inner core is an enteric coated ingot containing acetyl salicylic acid, and the outer layer contains a potassium ion competitive acid blocker which is not enteric coated. |